From the studies included in our systematic review, one study has analyzed the TGF-β expression in premalignant and malignant CR lesions, reporting a gradual increase in TGF-β expression levels and pointing at TGF-β regulation mode in the progression of CRC [68]. The gene discussed is TGFB1; the disease is colorectal carcinoma.